|
gptkbp:instanceOf
|
gptkb:chemical_compound
gptkb:drug
|
|
gptkbp:approvalYear
|
2001
|
|
gptkbp:approvedBy
|
gptkb:Japan
gptkb:United_States
gptkb:FDA
|
|
gptkbp:ATCCode
|
N07XX13
|
|
gptkbp:CASNumber
|
89-25-8
|
|
gptkbp:developedBy
|
gptkb:Mitsubishi_Tanabe_Pharma
|
|
gptkbp:discoveredBy
|
gptkb:Mitsubishi_Tanabe_Pharma
|
|
gptkbp:hasMolecularFormula
|
C10H10N2O
|
|
gptkbp:hasSMILES
|
CC1=C(C(=O)N(N1)C2=CC=CC=C2)
|
|
gptkbp:hasUNII
|
QXW8YN1B8J
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
edaravone
|
|
gptkbp:IUPACName
|
5-methyl-2-phenyl-4H-pyrazol-3-one
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
gptkb:Radicava
gptkb:Radicut
|
|
gptkbp:mechanismOfAction
|
free radical scavenger
|
|
gptkbp:meltingPoint
|
129-130°C
|
|
gptkbp:PubChem_CID
|
3884
4021
CHEMBL1201192
D01244
DB12243
|
|
gptkbp:routeOfAdministration
|
intravenous
|
|
gptkbp:sideEffect
|
headache
skin rash
abnormal kidney tests
contusion
gait disturbance
|
|
gptkbp:usedFor
|
amyotrophic lateral sclerosis
acute ischemic stroke
|
|
gptkbp:bfsParent
|
gptkb:Amyotrophic_lateral_sclerosis
|
|
gptkbp:bfsLayer
|
4
|